Karsinoma Laring
Published on June 26, 2026
Risk Factors
Male, age 55-65, chronic smoking and alcohol use (synergistic), occupational exposure (asbestos, wood dust, paint fumes), laryngopharyngeal reflux
Etiology
Squamous cell carcinoma (>95% of cases), arising from chronic mucosal irritation and carcinogen exposure; HPV plays a minor role compared to oropharyngeal carcinoma
Presentation
Persistent hoarseness lasting more than 3 weeks (glottic), dysphagia and sore throat (supraglottic), stridor and airway obstruction (subglottic, late)
Classic Exam
Exophytic or ulcerative mass on laryngoscopy, impaired or fixed vocal cord, cervical lymphadenopathy, referred otalgia (via Arnold nerve), cachexia in advanced cases
Diagnostics
Laryngoscopy showing a mucosal lesion, biopsy confirming squamous cell carcinoma, CT neck showing cartilage invasion or nodal enlargement
Management
Early glottic: radiation or transoral laser surgery. Intermediate/advanced: concurrent cisplatin-based chemoradiation for organ preservation; total laryngectomy for salvage or T4a disease
Keywords
"Smoker with persistent hoarseness," "vocal cord fixation," "referred otalgia," "organ preservation," "hoarseness more than 3 weeks"
01Pathophysiology
The larynx is divided into three anatomic subsites, and understanding this division is the single most important concept for exam questions on this topic. The supraglottis includes the epiglottis, aryepiglottic folds, false vocal cords, and the ventricle. The glottis includes the true vocal cords, the anterior commissure, and the posterior commissure. The subglottis extends from the undersurface of the true vocal cords to the inferior border of the cricoid cartilage.
Each subsite has a different lymphatic drainage density, and this directly determines the natural behavior and prognosis of the tumor. The glottis has virtually no lymphatic drainage. This is why glottic carcinoma rarely presents with cervical nodal metastasis and carries the best prognosis of the three subsites. In contrast, the supraglottis has a rich bilateral lymphatic network, which means supraglottic tumors frequently metastasize to bilateral cervical lymph nodes, even at early stages. Subglottic tumors drain to paratracheal and pretracheal nodes, though this subsite is rare (fewer than 5% of cases).
The pathophysiology also explains the presenting symptom pattern. The glottis is where phonation occurs. Even a small lesion on a true vocal cord disrupts its vibratory edge, producing early hoarseness. This is why glottic tumors are caught early. Supraglottic tumors, however, do not directly affect the vocal cords in early stages. Their initial symptoms are vague: mild sore throat, a globus sensation, or dysphagia. A classic and frequently tested presentation of supraglottic cancer is referred otalgia without otoscopic abnormality. This occurs because the supraglottis shares sensory innervation with the ear through the internal branch of the superior laryngeal nerve (a branch of the vagus) and Arnold nerve (auricular branch of the vagus). Subglottic tumors are essentially silent until they grow large enough to obstruct the airway, presenting as progressive stridor.
Over 95% of laryngeal carcinomas are squamous cell carcinoma, arising from the squamous epithelium lining the laryngeal mucosa. Chronic exposure to tobacco smoke and alcohol produces repeated mucosal injury, leading to a progression from hyperplasia to dysplasia to carcinoma in situ to invasive carcinoma. Smoking and alcohol have a multiplicative (synergistic) carcinogenic effect, not merely additive, making the combination far more dangerous than either alone.
02Classification and Clinical Manifestation
By Anatomic Subsite
Glottic
Frequency
60-65%
Lymphatic Drainage
Minimal
Typical Presenting Symptom
Early hoarseness
Nodal Metastasis at Diagnosis
Rare (<5% for T1)
Prognosis
Best
Supraglottic
Frequency
30-35%
Lymphatic Drainage
Rich, bilateral
Typical Presenting Symptom
Sore throat, dysphagia, referred otalgia
Nodal Metastasis at Diagnosis
Common (25-50%)
Prognosis
Intermediate
Subglottic
Frequency
1-5%
Lymphatic Drainage
Paratracheal nodes
Typical Presenting Symptom
Late stridor, airway obstruction
Nodal Metastasis at Diagnosis
Moderate
Prognosis
Worst
Subsite | Frequency | Lymphatic Drainage | Typical Presenting Symptom | Nodal Metastasis at Diagnosis | Prognosis |
|---|---|---|---|---|---|
Glottic | 60-65% | Minimal | Early hoarseness | Rare (<5% for T1) | Best |
Supraglottic | 30-35% | Rich, bilateral | Sore throat, dysphagia, referred otalgia | Common (25-50%) | Intermediate |
Subglottic | 1-5% | Paratracheal nodes | Late stridor, airway obstruction | Moderate | Worst |
TNM Staging (Glottic, most commonly tested)
T Stage | Description |
|---|---|
T1a | Tumor limited to one true vocal cord, with normal cord mobility |
T1b | Tumor involves both true vocal cords, with normal cord mobility |
T2 | Tumor extends to supraglottis or subglottis, and/or impaired vocal cord mobility |
T3 | Tumor causes vocal cord fixation, and/or invades the paraglottic space, and/or causes minor thyroid cartilage erosion |
T4a | Tumor invades through thyroid cartilage and/or extends to tissues beyond the larynx (trachea, deep extrinsic tongue muscles, strap muscles, thyroid, esophagus) |
T4b | Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures (unresectable) |
The single most tested staging concept is that vocal cord fixation automatically upgrades the tumor to at least T3, regardless of tumor size. This finding changes the management approach from radiation alone toward combined modality therapy.
03Diagnostic Workup
Flexible nasolaryngoscopy
Role
Best initial test
Key Findings
Visualizes the mass, assesses vocal cord mobility
Direct laryngoscopy with biopsy
Role
Most accurate (Gold Standard)
Key Findings
Histopathologic confirmation of squamous cell carcinoma
CT neck with contrast
Role
Staging (local and nodal)
Key Findings
Cartilage invasion, submucosal spread, lymphadenopathy
MRI neck
Role
Staging adjunct
Key Findings
Superior soft tissue resolution for pre-epiglottic space and cartilage invasion
CT chest
Role
Metastatic workup
Key Findings
Pulmonary metastases (most common distant site)
PET-CT
Role
Advanced disease staging
Key Findings
Nodal and distant metastasis assessment
Test | Role | Key Findings |
|---|---|---|
Flexible nasolaryngoscopy | Best initial test | Visualizes the mass, assesses vocal cord mobility |
Direct laryngoscopy with biopsy | Most accurate (Gold Standard) | Histopathologic confirmation of squamous cell carcinoma |
CT neck with contrast | Staging (local and nodal) | Cartilage invasion, submucosal spread, lymphadenopathy |
MRI neck | Staging adjunct | Superior soft tissue resolution for pre-epiglottic space and cartilage invasion |
CT chest | Metastatic workup | Pulmonary metastases (most common distant site) |
PET-CT | Advanced disease staging | Nodal and distant metastasis assessment |
Any patient presenting with hoarseness lasting more than 3 weeks, particularly a smoker or heavy alcohol user, requires direct visualization of the larynx. The best initial test is flexible nasolaryngoscopy performed in the clinic. This allows real-time assessment of the mucosal surface, tumor extent, and critically, vocal cord mobility. Cord mobility is not just a diagnostic detail; it determines T staging and dictates the treatment plan.
If a lesion is identified, the next step is direct laryngoscopy under general anesthesia with tissue biopsy. This is the gold standard. It provides histopathologic confirmation and allows a thorough examination of the entire upper aerodigestive tract, because patients with one squamous cell carcinoma of the head and neck are at risk for synchronous second primary tumors (the concept of "field cancerization"). Panendoscopy (laryngoscopy, esophagoscopy, bronchoscopy) is performed at this time.
Once the diagnosis is confirmed, CT of the neck with IV contrast is the primary imaging modality for locoregional staging. It evaluates the depth of invasion, thyroid cartilage involvement, pre-epiglottic space extension, and cervical nodal status. Nodes are considered pathologic when they measure over 1 cm in short axis, show central necrosis, or exhibit irregular enhancement. MRI is used as an adjunct when cartilage invasion is equivocal on CT, as MRI provides better soft tissue contrast.
A CT of the chest is performed to evaluate for pulmonary metastases, which represent the most common site of distant spread. PET-CT is reserved for advanced disease (stage III/IV) or when distant metastasis is suspected.
04Management and Treatment
T1-T2, N0 (Early Glottic)
Primary Treatment
Radiation therapy alone OR transoral laser microsurgery
Notes
Cure rate 85-95%. Voice preservation is the goal.
T1-T2, N0 (Early Supraglottic)
Primary Treatment
Radiation therapy alone OR supraglottic laryngectomy (open or transoral)
Notes
Neck dissection often included due to high nodal risk
T3, select T4a (Organ Preservation Candidate)
Primary Treatment
Concurrent chemoradiation: cisplatin IV on days 1, 22, and 43 with daily radiation (70 Gy over 7 weeks)
Notes
Based on organ preservation trials. Total laryngectomy reserved for salvage.
T4a with cartilage destruction
Primary Treatment
Total laryngectomy + postoperative radiation (+/- chemotherapy)
Notes
Organ preservation not appropriate when cartilage is destroyed
T4b (Unresectable)
Primary Treatment
Concurrent chemoradiation or palliative care
Notes
Carotid encasement or mediastinal invasion
Nodal Disease (N+)
Primary Treatment
Neck dissection (selective or modified radical)
Notes
Added to primary treatment; may be done before or after radiation
Post-laryngectomy
Primary Treatment
Tracheoesophageal puncture (TEP) for speech rehabilitation
Notes
Most effective voice restoration method after total laryngectomy
Stage | Primary Treatment | Notes |
|---|---|---|
T1-T2, N0 (Early Glottic) | Radiation therapy alone OR transoral laser microsurgery | Cure rate 85-95%. Voice preservation is the goal. |
T1-T2, N0 (Early Supraglottic) | Radiation therapy alone OR supraglottic laryngectomy (open or transoral) | Neck dissection often included due to high nodal risk |
T3, select T4a (Organ Preservation Candidate) | Concurrent chemoradiation: cisplatin IV on days 1, 22, and 43 with daily radiation (70 Gy over 7 weeks) | Based on organ preservation trials. Total laryngectomy reserved for salvage. |
T4a with cartilage destruction | Total laryngectomy + postoperative radiation (+/- chemotherapy) | Organ preservation not appropriate when cartilage is destroyed |
T4b (Unresectable) | Concurrent chemoradiation or palliative care | Carotid encasement or mediastinal invasion |
Nodal Disease (N+) | Neck dissection (selective or modified radical) | Added to primary treatment; may be done before or after radiation |
Post-laryngectomy | Tracheoesophageal puncture (TEP) for speech rehabilitation | Most effective voice restoration method after total laryngectomy |
Early-stage glottic carcinoma (T1-T2, N0) is one of the most curable solid malignancies. Both radiation therapy and transoral laser microsurgery (TLM) achieve cure rates above 85%. The choice between them depends on institutional expertise and the patient's priorities regarding voice quality. Radiation is delivered over 5-7 weeks. TLM has the advantage of being a single-session outpatient procedure with preserved voice in most cases and leaving radiation as a salvage option.
For intermediate and advanced laryngeal carcinoma (T3 and selected T4a), the landmark organ preservation trials established that concurrent chemoradiation with cisplatin can preserve the larynx without compromising overall survival compared to total laryngectomy. The standard regimen is high-dose cisplatin at on days 1, 22, and 43 of a 7-week course of definitive radiation therapy (total dose approximately 70 Gy). If the patient cannot tolerate cisplatin (e.g., renal insufficiency with , hearing loss, neuropathy), alternatives include carboplatin or cetuximab, though cisplatin remains the standard of care.
Total laryngectomy is reserved for T4a tumors with frank cartilage destruction (where organ preservation is not appropriate) and for salvage after failed chemoradiation. After total laryngectomy, the patient breathes through a permanent tracheostoma. Voice rehabilitation is achieved primarily through tracheoesophageal puncture (TEP) with a one-way valve, which is the most effective method. Esophageal speech and electrolarynx devices are alternatives.
Contraindications and considerations: In patients with poor renal function, cisplatin must be replaced. In patients with a second primary or field cancerization, careful surveillance of the entire aerodigestive tract is needed. Patients treated with radiation for early glottic cancer require close follow-up with laryngoscopy every 1-3 months in the first two years, as early detection of recurrence allows salvage laryngectomy with good outcomes.
05Differential Diagnosis and Distractors
Vocal cord polyp/nodule
Why It Is Similar
Hoarseness in a middle-aged patient, history of voice overuse
Key Discriminator
Bilateral nodules at the junction of the anterior and middle third of the cord; smooth, non-ulcerated; typically in voice professionals; no risk factors for malignancy
Laryngeal papilloma (Recurrent Respiratory Papillomatosis)
Why It Is Similar
Exophytic laryngeal mass causing hoarseness
Key Discriminator
Caused by HPV 6 and 11 (not high-risk HPV); multiple papillomatous growths; tends to recur after excision; more common in children (juvenile onset) or young adults
Reinke edema (polypoid corditis)
Why It Is Similar
Hoarseness in a chronic smoker; diffuse vocal cord swelling
Key Discriminator
Bilateral diffuse boggy swelling of the entire vocal cord, not a focal ulcerated mass; low-pitched voice is characteristic
Laryngeal tuberculosis
Why It Is Similar
Hoarseness, weight loss, lesion on laryngoscopy; may coexist with pulmonary TB
Key Discriminator
Usually involves the posterior glottis (interarytenoid region); chest X-ray shows pulmonary TB findings; sputum AFB positive; biopsy shows caseating granulomas, not squamous cell carcinoma
Supraglottic cancer vs. Hypopharyngeal cancer
Why It Is Similar
Both can present with dysphagia, odynophagia, referred otalgia, and a neck mass
Key Discriminator
Hypopharyngeal tumors (pyriform sinus) tend to present with more prominent dysphagia and pooling of secretions in the pyriform sinus on laryngoscopy; they carry a worse prognosis due to later presentation and richer submucosal spread
GERD/Laryngopharyngeal reflux (LPR)
Why It Is Similar
Chronic hoarseness, throat clearing, globus sensation
Key Discriminator
No discrete mass on laryngoscopy; posterior laryngeal edema and erythema (pachydermia); responds to proton pump inhibitor therapy
Differential | Why It Is Similar | Key Discriminator |
|---|---|---|
Vocal cord polyp/nodule | Hoarseness in a middle-aged patient, history of voice overuse | Bilateral nodules at the junction of the anterior and middle third of the cord; smooth, non-ulcerated; typically in voice professionals; no risk factors for malignancy |
Laryngeal papilloma (Recurrent Respiratory Papillomatosis) | Exophytic laryngeal mass causing hoarseness | Caused by HPV 6 and 11 (not high-risk HPV); multiple papillomatous growths; tends to recur after excision; more common in children (juvenile onset) or young adults |
Reinke edema (polypoid corditis) | Hoarseness in a chronic smoker; diffuse vocal cord swelling | Bilateral diffuse boggy swelling of the entire vocal cord, not a focal ulcerated mass; low-pitched voice is characteristic |
Laryngeal tuberculosis | Hoarseness, weight loss, lesion on laryngoscopy; may coexist with pulmonary TB | Usually involves the posterior glottis (interarytenoid region); chest X-ray shows pulmonary TB findings; sputum AFB positive; biopsy shows caseating granulomas, not squamous cell carcinoma |
Supraglottic cancer vs. Hypopharyngeal cancer | Both can present with dysphagia, odynophagia, referred otalgia, and a neck mass | Hypopharyngeal tumors (pyriform sinus) tend to present with more prominent dysphagia and pooling of secretions in the pyriform sinus on laryngoscopy; they carry a worse prognosis due to later presentation and richer submucosal spread |
GERD/Laryngopharyngeal reflux (LPR) | Chronic hoarseness, throat clearing, globus sensation | No discrete mass on laryngoscopy; posterior laryngeal edema and erythema (pachydermia); responds to proton pump inhibitor therapy |
06Traps and High-Yield Pearls
The most common way students get this topic wrong is by failing to connect the anatomic subsite to the clinical behavior. When a vignette describes a patient with early hoarseness and no palpable neck mass, students sometimes do not recognize that this points to a glottic primary with an excellent prognosis. Conversely, when a vignette describes referred otalgia, dysphagia, and bilateral cervical nodes, students may not realize this points to a supraglottic primary with a higher stage at presentation.
A second frequent trap involves vocal cord fixation. A vignette may describe a "small tumor" on the vocal cord, but then mention that the cord is immobile on examination. Students who focus on tumor size and call it early-stage disease will miss that cord fixation automatically makes this at least T3, which shifts the management from radiation alone toward chemoradiation or surgery.
The third trap relates to referred otalgia. A patient with ear pain and a normal otoscopic examination should raise suspicion for a head and neck malignancy, not an ear problem. Students who pursue an otologic workup instead of examining the larynx and pharynx will miss the diagnosis entirely.
Finally, students confuse the role of total laryngectomy in the modern era. The tested concept is that organ preservation with concurrent chemoradiation is the standard approach for T3 and selected T4a laryngeal cancer, and total laryngectomy is reserved for cases with cartilage destruction or as salvage for chemoradiation failure. Choosing upfront total laryngectomy for a T3 tumor when organ preservation is an option is a common wrong answer.
The core competency being tested is the student's ability to localize a tumor within the larynx based on symptom pattern, apply that localization to predict staging and prognosis, and select the correct management pathway based on stage.